These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9764824

  • 1. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
    Oh Y, Proctor ML, Fan YH, Su LK, Hong WK, Fong KM, Sekido YS, Gazdar AF, Minna JD, Mao L.
    Oncogene; 1998 Sep 03; 17(9):1141-8. PubMed ID: 9764824
    [Abstract] [Full Text] [Related]

  • 2. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA, Barski P, Batley SJ, Li L, de Foy KA, Cohen SN, Ponder BA, Caldas C.
    Oncogene; 1997 Oct 23; 15(17):2119-26. PubMed ID: 9366528
    [Abstract] [Full Text] [Related]

  • 3. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 4. Role of TSG101 in uterine cervix cancer.
    O'Boyle JD, Proctor ML, Fong KM, Lin WM, Miller DS, Muller CY.
    Gynecol Oncol; 1999 Dec 01; 75(3):401-5. PubMed ID: 10600297
    [Abstract] [Full Text] [Related]

  • 5. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B, Grebe SK, Wang L, Hay ID, Yokomizo A, Liu W, Goellner JR, Grant CS, Smith DI, Eberhardt NL.
    Clin Endocrinol (Oxf); 2000 Jun 01; 52(6):749-57. PubMed ID: 10848880
    [Abstract] [Full Text] [Related]

  • 6. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
    Willeke F, Ridder R, Bork P, Klaes R, Mechtersheimer G, Schwarzbach M, Zimmer D, Kloor M, Lehnert T, Herfarth C, von Knebel Doeberitz M.
    Mol Carcinog; 1998 Dec 01; 23(4):195-200. PubMed ID: 9869447
    [Abstract] [Full Text] [Related]

  • 7. [Expression and its significance of TSG101 in lung cancer tissue and lung cancer cell lines.].
    Cai C, Zhang D, Lu P, Gao Y, Chang J.
    Zhongguo Fei Ai Za Zhi; 2008 Apr 20; 11(2):172-7. PubMed ID: 20731896
    [Abstract] [Full Text] [Related]

  • 8. Absence of TSG101 transcript abnormalities in human cancers.
    Trink B, Pai SI, Spunt SL, Raman V, Cairns P, Jen J, Gabrielson E, Sukumar S, Sidransky D.
    Oncogene; 1998 May 28; 16(21):2815-8. PubMed ID: 9652749
    [Abstract] [Full Text] [Related]

  • 9. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.
    Hosokawa Y, Nagai E, Seto M.
    J Cancer Res Clin Oncol; 2000 Feb 28; 126(2):79-84. PubMed ID: 10664246
    [Abstract] [Full Text] [Related]

  • 10. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
    Sekine I, Sato M, Sunaga N, Toyooka S, Peyton M, Parsons R, Wang W, Gazdar AF, Minna JD.
    Oncogene; 2005 Apr 14; 24(16):2735-8. PubMed ID: 15735765
    [Abstract] [Full Text] [Related]

  • 17. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D.
    Cancer Res; 1997 Dec 01; 57(23):5356-9. PubMed ID: 9393760
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.
    Nat Genet; 2000 Jul 01; 25(3):315-9. PubMed ID: 10888881
    [Abstract] [Full Text] [Related]

  • 19. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S.
    Oncol Rep; 2006 Mar 01; 15(3):545-9. PubMed ID: 16465410
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.
    Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Rusin MR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwala M.
    Cancer Res; 1995 Apr 01; 55(7):1448-51. PubMed ID: 7882351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.